Breast Cancer

Filters

Online Exclusive

SALE UP TO 25% OFF

Shop The Sale
售罄

瑞波西利(凯丽隆)200mg×63片 | 诺华中国来源 | GLT

中国来源诺华凯丽隆(瑞波西利)200mg 63片,NMPA 批准并纳入医保,用于 HR+/HER2- 乳腺癌。
售罄

赫赛莱 恩美曲妥珠单抗(T-DM1)100/160mg | 罗氏中国原研 | GLT

获 NMPA 批准的罗氏赫赛莱(恩美曲妥珠单抗,T-DM1)100mg 及 160mg 瓶装,中国原研、靶向 HER2 的抗体偶联药物(ADC)。
售罄

Kadcyla Ado-trastuzumab Emtansine (T-DM1) 100/160mg | Roche EU Originator | GLT

EMA-approved Roche Kadcyla ado-trastuzumab emtansine (T-DM1) 100mg & 160mg vials, EU originator HER2-targeted ADC.
售罄

Pivikto (Alpelisib) 150mg 28 Tablets | Novartis India Original | GLT

Pivikto — Novartis India's original alpelisib brand, the most affordable genuine original for PIK3CA-mutated breast...
售罄

Piqray (Alpelisib) 150mg 56 Tablets | Novartis Hong Kong Original | GLT

Piqray Hong Kong original — 56 tablets = one 28-day treatment month, Novartis, approved in...
售罄

Piqray (Alpelisib) 150mg/200mg Tablets | Novartis Germany Original | GLT

Piqray — the Novartis original PI3Kα inhibitor for PIK3CA-mutated HR+/HER2- breast cancer, German original cartons
排序
  • 推荐
  • 价格由低到高
  • 价格由高到底
  • 最新
  • 销量最高